Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+13.77%
-2.28%
-14.01%
-12.17%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
27 Feb 2026$ENSC exploded 57.77% to $0.62 on a staggering 274.6 million shares versus just 1.84 million average volume. The catalyst was the initiation of a strategic alternatives review, which often signals potential asset sales, partnerships, or even a buyout. The market clearly priced in optionality. When a micro-cap trades nearly 150x its average volume, it tells me speculation is running hot and momentum traders are firmly in control.
$ALBT rallied 36.7% to $1.49 after announcing a $9.75 million private placement. Volume reached 36.2 million shares against an 11.4 million average. Capital raises can cut both ways, but in this case the market appears to be rewarding balance sheet reinforcement and growth funding. The key question is dilution versus deployment efficiency.
$ARLO surged 27.04% to $15.69 on 5.14 million shares, almost 4x its 1.3 million, following its Q4 earnings release. Investors seem to be focusing on operating leverage and forward metrics rather than just headline EPS. Strong subscription momentum and improved margins likely fueled confidence that recurring revenue is becoming the dominant driver.
$BWIN gained 25.64% to $23.23 with volume doubling its norm after earnings results and a five-day winning streak. The move suggests the market is repricing growth durability in the insurance brokerage model. If organic growth trends and commission stability hold, the rally may have more fundamental backing than typical small-cap spikes.
$CDIO climbed 25.48% to $6.55 on 18.3 million shares versus a 6.5 million average, riding the broader premarket biotech momentum wave. While no specific earnings catalyst drove it, sector sympathy and speculative capital rotation into diagnostics and precision medicine appear to be the fuel.
$FIGS jumped 23.9% to $15.45 on 23.1 million shares compared to 2.9 million avg after delivering strong earnings and guiding for double-digit revenue growth. Hitting a near four-year high signals institutions are rewarding consistent brand strength and margin expansion in the healthcare apparel niche. This move feels structurally stronger than a typical short squeeze.
$DELL advanced 21.93% to $148.08 on 33.2 million shares versus 7.8 million average after beating Q4 earnings expectations and issuing FY27 guidance above estimates. Revenue of $33.38 billion and EPS of $3.89 outpaced consensus, reinforcing the AI infrastructure narrative. This is not just retail enthusiasm; it reflects institutional repricing of AI server demand and margin expansion potential.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Pro Members
